CD19/22 Bi-specific CAR-T Cell Therapy
CD19/22 Bi-specific CAR-T Cell Therapy
Not yet recruiting · NCT05432882 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD19/22 Bi-specific CAR-T Cell Therapy | B Cell Malignancies | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-26 | NCT05432882 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 43 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shenzhen Geno-Immune Medical Institute | Shenzhen | China | 39 |